Navigation Links
PCMA on IOM Essential Health Benefits Report: Employers and Special Interests Will Spar Over Costly Prescription Drug Mandates
Date:10/7/2011

WASHINGTON, Oct. 7, 2011 /PRNewswire-USNewswire/ -- By urging the U.S. Department of Health and Human Services (HHS) to issue "Essential Health Benefits" regulations that ensure affordable, flexible benefits in the exchanges, the Institute of Medicine (IOM) has launched a long-overdue debate between employers and some powerful special interests that benefit from costly new mandates, according to the Pharmaceutical Care Management Association (PCMA).

A new survey shows that small employers strongly oppose many of the regulations that special interests routinely ask HHS to impose on plans that offer drug coverage.  These include restrictions on mail-service pharmacy, drugstore networks, generic drugs, pricing models, and overall benefit design.

"On prescription drug issues, employers want access to affordable plans that promote mail-service pharmacy, offer less expensive drugstore networks, and don't require small businesses to bear the full cost of drugs that can cost $100,000 or more.  Some powerful special interests, however, profit from mandates that prohibit plans from offering these options in the exchanges," said PCMA President and CEO Mark Merritt.

Small businesses will be among those most affected by the Essential Health Benefit rules, which apply to employers that purchase coverage and have fewer than one hundred employees, as well as qualified health plans in the state exchanges.  Pharmacy benefit managers (PBMs) administer drug benefits for thousands of small businesses throughout America.

The survey of owners and human resource managers of small businesses with 100 or fewer employees directly impacted by the upcoming Essential Health Benefits regulations found that by a 78 to 11 percent margin, "small businesses should be able to reduce prescription drug costs as much as possible, even if it means drugstores make less profit." Only six percent were interested in knowing how much drugstores are paid.

Small businesses disagree with the drugstore and drug company lobbies on the following issues:

* Small businesses want access to plans that exclude expensive drugstores from their networks. 61 percent say it is a good idea to "allow employers to choose lower cost plans that exclude the most expensive drugstores from their coverage network."

* Seventy-four percent oppose mandating across-the-board, low co-pays for high-priced drugs. By a 2-1 margin, small businesses think it would be better to require drug companies to offer case-by-case price discounts to those in need.

* Small businesses want to hold drugstores accountable. 88 percent say it is a good idea to "allow plans to audit drugstores that appear to be overcharging."

* Small businesses want access to plans that encourage delivery of prescription drugs through the mail. 79 percent say it is a good idea to "allow plans to offer discounts that encourage employees to get prescriptions by mail."

A new PCMA ad campaign highlights that small businesses oppose regulations that would allow special interests to raise prescription drug costs.  Click here to view the ad.  

 


'/>"/>
SOURCE Pharmaceutical Care Management Association
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Nationwide Survey Reports that Mothers View Cleaning Homes and Toys as Essential to Preventing Colds & Flu
2. Precise Low-Dose Drug Monitoring Essential for Long-Term Kidney Transplant Success
3. Essentialis Completes Patient Enrollment in Phase 2 Trial of DDCR for Treatment of Dyslipidemia
4. Essentialis Meets Primary Endpoint in Phase 2b Trial of DCCR for Treatment of Hypertriglyceridemia and is Granted Extensive Patent Coverage in the US
5. Essentialis to Submit SPA for Hypertriglyceridemia
6. Weekly Digests Investor Essentials Special Report Identifies Unique Investing Opportunities in the H1N1 Swine Flu Outbreak
7. Creative Alliances with Nontraditional Players Increasingly Essential for Survival in Pharmaceutical Industry, New Ernst & Young Report Finds
8. Health Outcomes Data Essential to Biopharmaceutical Sales Process
9. Laerdal Introduces SimMan Essential
10. Essentialis Strengthens Patent Protection of Its Novel ATP-Sensitive Potassium Channel Opener Portfolio
11. Essential Pharmaceuticals Acquires Exclusive Worldwide Rights to Family of Cell Media Products from Lifeblood Medical
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... DUBLIN , April 20, 2017 ... "Latin America Pharmaceutical Contract Manufacturing Services Market Analysis By Service ... And Segment Forecasts, 2014 - 2025" report to their ... The Latin ... USD 21.0 billion by 2025 Low drug registration ...
(Date:4/19/2017)... NEW YORK , April 19, 2017 ... Surgical drainage devices are tubes used to remove excess ... include, blood, serum, pus, urine, bile or lymph. Surgical ... types of surgery such as orthopedics surgery, cardiovascular surgery, ... device is prophylactic post-surgery to prevent accumulation of fluid ...
(Date:4/19/2017)... Companion animal vaccines ... pets such as canine, avian and feline. ... such as Attenuated Live Vaccines, Conjugate Vaccines, Inactivated ... Recombinant Vaccines. Attenuated live vaccines are derived from ... have been weakend under laboratory conditions. Conjugate vaccines ...
Breaking Medicine Technology:
(Date:4/26/2017)... ... ... Miami native and local periodontist Dr. John Paul Gallardo is celebrating ... 1991 that this journey would have taken me into so many learning experiences both ... has pioneered implant dentistry innovation, evolving into an internationally recognized leader in the industry. ...
(Date:4/26/2017)... , ... April 26, 2017 , ... ... today launched a unique website ( CRISPRCas.pioneer.com ) that demonstrates how this advanced ... farmers produce more and better food, with fewer resources. It highlights the business’ ...
(Date:4/26/2017)... Doylestown, Pa. (PRWEB) , ... ... ... Solutions division, which provides an agile ecosystem and domain expertise for sponsors ... end-to-end, configurable randomization and trial supply management (RTSM) software platform. Bioclinica ...
(Date:4/25/2017)... ... April 25, 2017 , ... Bellus Medical, a ... first in a new class of photodynamic cosmetics (PDC). , Allumera® is the ... reduce outward signs of aging, and minimize the appearance of pores – all ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... agreement to be the preferred physical therapy provider for Derby City CrossFit, effective ... Derby City CrossFit as quickly and effectively as possible, ProRehab’s sports physical therapists ...
Breaking Medicine News(10 mins):